Kelly Tyler, MD
Dermatology · Columbus, OHNPI 1952523722
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $1,108 of the $1,327 with a category attached, or 83.5%. Every reported general payment came from a single manufacturer, Bristol Myers Squibb. That places this record below the midpoint for dermatology clinicians in OH, where the typical reported total is $2,374.
Across 6 payments — averaging $221.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bristol Myers Squibb$1K
Across 51 payments — averaging $7879.68 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Janssen Research & Development, LLC$150K
- Amgen$147K
- Bristol Myers Squibb$58K
- Novartis$47K
What the payments were for
- Travel & lodging$1,10884%
- Food & beverage$21916%
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bristol Myers Squibb | 6 | $1,327 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Otezla$1,207
How this compares
$1,327 in reported general payments places this provider in the 40th percentile of 460 dermatology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Taltz SyringeIxekizumab | 14 | $97,315 |
| Dupixent SyringeDupilumab | 14 | $46,013 |
| Clobetasol Propionate | 61 | $3,622 |
| Estradiol | 26 | $2,168 |
| Ketoconazole | 147 | $1,734 |
| Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc | 47 | $1,425 |
| Doxycycline Hyclate | 16 | $1,254 |
| Fluocinonide | 33 | $1,180 |
| Triamcinolone Acetonide | 135 | $1,086 |
| Ciclopirox | 25 | $991 |
| Metronidazole | 17 | $851 |
| Tretinoin | 12 | $548 |
| Hydrocortisone | 100 | $398 |
| Gabapentin | 18 | $327 |
| Spironolactone | 15 | $209 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Columbus
- Nicholas BennerColumbus$356K
- Stephanie FabbroColumbus$82K
- Shari Hicks-GrahamColumbus$68K
- Benjamin KaffenbergerColumbus$24K
- Gwyn LondereeColumbus$20K
- Matthew ZirwasBexley$3.3M
- George DrewMarion$1.9M
- Rocco SerraoDayton$1.7M
- James LibeccoFairlawn$1.1M
- Pranav ShethWest Chester$978K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.